ONCT: Oncternal Therapeutics, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Oncternal Therapeutics, Inc.

NASDAQ:ONCT

SummaryFactSheetFinancial
Price
$7.03
Loss Chance
58.0%
1.83JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Alexion Pharmaceuticals
NASDAQ:ALXN
6.89
$182.50
52.20%
Amgen
NASDAQ:AMGN
6.24
$339.30
38.98%
Arena Pharmaceuticals
NASDAQ:ARNA
0.01
$99.99
100.00%
Biogen
NASDAQ:BIIB
5.83
$193.76
12.58%
Celgene Corporation
NASDAQ:CELG
8.55
$108.24
17.72%
Jitta Factors
Growth Opportunity (0)
Recent Business Performance (30)
Financial Strength (10)
Return to Shareholders (0)
Competitive Advantage (0)
Jitta Signs
Recent Business PerformanceEarning decline 66.94% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
1.82
100.00%
2.22
139.24%
n/a
n/a
Biotechnology
6.24
38.98%
0.01
100.00%
5.83
12.58%
COMPANY DESCRIPTION
As of June 7, 2019, GTx, Inc. was acquired by Oncternal Therapeutics, Inc., in a reverse merger transaction. GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for the treatment of stress urinary incontinence (SUI) and prostate cancer. It develops selective androgen receptor modulators (SARMs) for the treatment of breast cancer, SUI, and Duchenne muscular dystrophy; and selective androgen receptor degraders to treat progressive castration-resistant prostate cancer. The company’s SARM product candidate is the enobosarm GTx-024, a Phase II proof-of-concept clinical trial for patients with androgen receptor (AR) positive triple-negative breast cancer; and estrogen receptor positive and AR positive advanced breast cancer, as well as postmenopausal women with SUI. GTx, Inc. was founded in 1997 and is headquartered in Memphis, Tennessee.
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.